Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection.
Saved in:
| Title: | Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection. |
|---|---|
| Authors: | Delphin M; The Francis Crick Institute, London, UK., Mohammed KS; The Francis Crick Institute, London, UK; Division of Biosciences, Faculty of Life Sciences, University College London, London, UK., Downs LO; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Lumley SF; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford, UK., Waddilove E; The Francis Crick Institute, London, UK., Okanda D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Aliyan N; Kilifi County Hospital, Kilifi, Kenya., Van Schalkwyk M; Division of Infectious Diseases, Department of Medicine, Stellenbosch University-Tygerberg Academic Hospital, Cape Town, South Africa., Anderson M; The Francis Crick Institute, London, UK; Botswana Harvard AIDS Institute Partnership, Princess Marina Hospital, Gaborone, Botswana; Africa Health Research Institute, Durban, South Africa., Ocama P; College of Health Sciences, Makerere University, Kampala, Uganda., Maponga T; Division of Medical Virology, Stellenbosch University-National Health Laboratory Service Tygerberg Business Unit, Cape Town, South Africa., Torimiro J; Molecular Biology Laboratory, Chantal Biya International Reference Centre for AIDS Research, Yaounde, Cameroon., Iwuji C; Africa Health Research Institute, Durban, South Africa; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Ndung'u T; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, Durban, South Africa., Matthews PC; The Francis Crick Institute, London, UK; Division of Infection and Immunity, University College London, London, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases, University College London Hospital, London, London, UK. Electronic address: philippa.matthews@crick.ac.uk., Taljaard J; Division of Infectious Diseases, Department of Medicine, Stellenbosch University-Tygerberg Academic Hospital, Cape Town, South Africa. |
| Source: | The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Apr; Vol. 9 (4), pp. 383-392. Date of Electronic Publication: 2024 Feb 15. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38367632 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Delphin+M%22">Delphin M</searchLink>; The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Mohammed+KS%22">Mohammed KS</searchLink>; The Francis Crick Institute, London, UK; Division of Biosciences, Faculty of Life Sciences, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Downs+LO%22">Downs LO</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Lumley+SF%22">Lumley SF</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Waddilove+E%22">Waddilove E</searchLink>; The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Okanda+D%22">Okanda D</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Aliyan+N%22">Aliyan N</searchLink>; Kilifi County Hospital, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Van+Schalkwyk+M%22">Van Schalkwyk M</searchLink>; Division of Infectious Diseases, Department of Medicine, Stellenbosch University-Tygerberg Academic Hospital, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Anderson+M%22">Anderson M</searchLink>; The Francis Crick Institute, London, UK; Botswana Harvard AIDS Institute Partnership, Princess Marina Hospital, Gaborone, Botswana; Africa Health Research Institute, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Ocama+P%22">Ocama P</searchLink>; College of Health Sciences, Makerere University, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Maponga+T%22">Maponga T</searchLink>; Division of Medical Virology, Stellenbosch University-National Health Laboratory Service Tygerberg Business Unit, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Torimiro+J%22">Torimiro J</searchLink>; Molecular Biology Laboratory, Chantal Biya International Reference Centre for AIDS Research, Yaounde, Cameroon.<br /><searchLink fieldCode="AU" term="%22Iwuji+C%22">Iwuji C</searchLink>; Africa Health Research Institute, Durban, South Africa; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Ndung'u+T%22">Ndung'u T</searchLink>; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Matthews+PC%22">Matthews PC</searchLink>; The Francis Crick Institute, London, UK; Division of Infection and Immunity, University College London, London, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases, University College London Hospital, London, London, UK. Electronic address: philippa.matthews@crick.ac.uk.<br /><searchLink fieldCode="AU" term="%22Taljaard+J%22">Taljaard J</searchLink>; Division of Infectious Diseases, Department of Medicine, Stellenbosch University-Tygerberg Academic Hospital, Cape Town, South Africa. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101690683%22">The lancet. Gastroenterology & hepatology</searchLink> [Lancet Gastroenterol Hepatol] 2024 Apr; Vol. 9 (4), pp. 383-392. <i>Date of Electronic Publication: </i>2024 Feb 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101690683 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2468-1253 (Electronic) <i>NLM ISO Abbreviation: </i>Lancet Gastroenterol Hepatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38367632 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S2468-1253(23)00315-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 383 Titles: – TitleFull: Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Delphin M – PersonEntity: Name: NameFull: Mohammed KS – PersonEntity: Name: NameFull: Downs LO – PersonEntity: Name: NameFull: Lumley SF – PersonEntity: Name: NameFull: Waddilove E – PersonEntity: Name: NameFull: Okanda D – PersonEntity: Name: NameFull: Aliyan N – PersonEntity: Name: NameFull: Van Schalkwyk M – PersonEntity: Name: NameFull: Anderson M – PersonEntity: Name: NameFull: Ocama P – PersonEntity: Name: NameFull: Maponga T – PersonEntity: Name: NameFull: Torimiro J – PersonEntity: Name: NameFull: Iwuji C – PersonEntity: Name: NameFull: Ndung'u T – PersonEntity: Name: NameFull: Matthews PC – PersonEntity: Name: NameFull: Taljaard J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2468-1253 Numbering: – Type: volume Value: 9 – Type: issue Value: 4 Titles: – TitleFull: The lancet. Gastroenterology & hepatology Type: main |
| ResultId | 1 |